Keywords: sandoz, mdr, drug, shows, promise, early, trials

Sandoz MDR Drug Shows Promise In Early Trials

Article | 13 November 1995

Print This

It is now well established that P-glycoprotein, the product of the multidrug resistance (MDR-1) gene, is one of the key ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in